EcoDrugPlus

Eph Receptor B4

Ensembl ID : ENSLACG00000002978
Gene Symbol: EPHB4
3 Cross references
169 Possible Orthologues:

Fau Ubiquitin Like And Ribosomal Protein S30 Fusion

Ensembl ID : ENSLACG00000007528
Gene Symbol: FAU
4 Cross references
302 Possible Orthologues:

Fkbp Prolyl Isomerase 1a

Ensembl ID : ENSLACG00000010882
Gene Symbol: FKBP1A
4 Cross references
480 Possible Orthologues:

Fyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSLACG00000012800
Gene Symbol: FYN
4 Cross references
261 Possible Orthologues:

Il2 Inducible T Cell Kinase

Ensembl ID : ENSLACG00000014337
Gene Symbol: ITK
4 Cross references
207 Possible Orthologues:

Janus Kinase 1

Ensembl ID : ENSLACG00000006843
Gene Symbol: JAK1
4 Cross references
234 Possible Orthologues:

Janus Kinase 2

Ensembl ID : ENSLACG00000006173
Gene Symbol: JAK2
4 Cross references
265 Possible Orthologues:

Kit Proto-Oncogene, Receptor Tyrosine Kinase

Ensembl ID : ENSLACG00000003897
Gene Symbol: KIT
3 Cross references
265 Possible Orthologues:

Kras Proto-Oncogene, Gtpase

Ensembl ID : ENSLACG00000017464
Gene Symbol: KRAS
4 Cross references
207 Possible Orthologues:

Lck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSLACG00000013039
Gene Symbol: LCK
4 Cross references
120 Possible Orthologues:

Lyn Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSLACG00000005733
Gene Symbol: LYN
4 Cross references
202 Possible Orthologues:

Malt1 Paracaspase

Ensembl ID : ENSLACG00000003695
Gene Symbol: MALT1
4 Cross references
195 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).